Biblio

Export 270 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Middle Aged  [Clear All Filters]
2018
K. Katisko, Haapasalo, A., Koivisto, A., Krüger, J., Hartikainen, P., Korhonen, V., Helisalmi, S., Herukka, S. - K., Remes, A. M., and Solje, E., “Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 2, pp. 789-794, 2018.
A. Synn, Mothakunnel, A., Kumfor, F., Chen, Y., Piguet, O., Hodges, J. R., and Irish, M., “Mental States in Moving Shapes: Distinct Cortical and Subcortical Contributions to Theory of Mind Impairments in Dementia.”, J Alzheimers Dis, vol. 61, no. 2, pp. 521-535, 2018.
P. R. Manzine, Pelucchi, S., Horst, M. A., Vale, F. A. C., Pavarini, S. C. I., Audano, M., Mitro, N., Di Luca, M., Marcello, E., and Cominetti, M. R., “microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.
X. - Q. Che, Zhao, Q. - H., Huang, Y., Li, X., Ren, R. - J., Di Chen, S. -, Guo, Q. - H., and Wang, G., “Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1283-1288, 2018.
S. Sapkota and Dixon, R. A., “A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 62, no. 2, pp. 887-900, 2018.
A. Slachevsky, Barraza, P., Hornberger, M., Muñoz-Neira, C., Flanagan, E., Henriquez, F., Bravo, E., Farías, M., and Delgado, C., “Neuroanatomical Comparison of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 589-600, 2018.
T. Ming Liew, Yu, J., Mahendran, R., Ng, T. - P., Kua, E. - H., and Feng, L., “Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis.”, J Alzheimers Dis, vol. 62, no. 2, pp. 675-686, 2018.
R. J. Dougherty, Lindheimer, J. B., Stegner, A. J., Van Riper, S., Okonkwo, O. C., and Cook, D. B., “An Objective Method to Accurately Measure Cardiorespiratory Fitness in Older Adults Who Cannot Satisfy Widely Used Oxygen Consumption Criteria.”, J Alzheimers Dis, vol. 61, no. 2, pp. 601-611, 2018.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., “Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C., “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
P. Siddarth, Rahi, B., Emerson, N. D., Burggren, A. C., Miller, K. J., Bookheimer, S., Lavretsky, H., Dobkin, B., Small, G., and Merrill, D. A., “Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
Q. Tao, Zhu, H., Chen, X., Stern, R. A., Kowall, N., Au, R., Blusztajn, J. Krzysztof, and Qiu, W. Qiao, “Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
C. Lange, Suppa, P., Pietrzyk, U., Makowski, M. R., Spies, L., Peters, O., and Buchert, R., “Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.”, J Alzheimers Dis, vol. 61, no. 1, pp. 373-388, 2018.
A. Sinai, Mokrysz, C., Bernal, J., Bohnen, I., Bonell, S., Courtenay, K., Dodd, K., Gazizova, D., Hassiotis, A., Hillier, R., McBrien, J., McCarthy, J., Mukherji, K., Naeem, A., Perez-Achiaga, N., Rantell, K., Sharma, V., Thomas, D., Walker, Z., Whitham, S., and Strydom, A., “Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 717-728, 2018.
M. Serpente, Fenoglio, C., Cioffi, S. Maria Giul, Oldoni, E., Arcaro, M., Arighi, A., Fumagalli, G. Giulio, Ghezzi, L., Scarpini, E., and Galimberti, D., “Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1289-1294, 2018.
I. M. Rosa, Henriques, A. G., Wiltfang, J., and Silva, O. A. B. da Cru, “Putative Dementia Cases Fluctuate as a Function of Mini-Mental State Examination Cut-Off Points.”, J Alzheimers Dis, vol. 61, no. 1, pp. 157-167, 2018.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
M. L. Sanders, Stuckenschneider, T., Devenney, K. E., Lawlor, B., Schneider, S., and Rikkert, M. G. M. Olde, “Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal.”, J Alzheimers Dis, vol. 62, no. 2, pp. 579-581, 2018.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
R. Zanardini, Benussi, L., Fostinelli, S., Saraceno, C., Ciani, M., Borroni, B., Padovani, A., Binetti, G., and Ghidoni, R., “Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1053-1060, 2018.
S. C. McEwen, Siddarth, P., Abedelsater, B., Kim, Y., Mui, W., Wu, P., Emerson, N. D., Lee, J., Greenberg, S., Shelton, T., Kaiser, S., Small, G. W., and Merrill, D. A., “Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments.”, J Alzheimers Dis, vol. 62, no. 2, pp. 795-806, 2018.
E. Gómez-Tortosa, Ruggiero, M., Sainz, M. José, Villarejo-Galende, A., Prieto-Jurczynska, C., Pérez, B. Venegas, Ordás, C., Agüero, P., Guerrero-López, R., and Pérez-Pérez, J., “SORL1 Variants in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1275-1281, 2018.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.

Pages